DCF — AMERY REGIONAL MEDICAL CENTER
Enterprise Value: $-23.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-23.0M
Enterprise Value
$-9.2M
PV of Cash Flows
$-13.7M
PV of Terminal Value
$-22.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $73.0M | $-0.4M | -0.0% | $-3.4M | $-3.1M |
| Year 2 | $75.2M | $0.4M | 1.0% | $-2.8M | $-2.3M |
| Year 3 | $77.5M | $1.2M | 2.0% | $-2.1M | $-1.6M |
| Year 4 | $79.8M | $1.6M | 2.0% | $-1.8M | $-1.2M |
| Year 5 | $82.2M | $1.9M | 2.0% | $-1.6M | $-1.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-23.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$70.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0098595350395311
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5